Medical Device and Life Sciences Co-Development Company Raise Funds to Accelerate Growth and Expand Reach.NEWARK, Calif., Feb. 1, 2024 /PRNewswire/ -- Triple Ring Technologies ('Triple Ring'), The Co-Development Company for Medical Device and Life Sciences, proudly announces a significant growth capital investment from 1315 Capital, a Philadelphia-based, healthcare-focused growth equity firm.

医疗器械和生命科学共同开发公司筹集资金以加速增长并扩大覆盖范围。加利福尼亚州纽瓦克，2024年2月1日，医疗器械和生命科学联合开发公司Triple-Ring Technologies（“Triple-Ring”）骄傲地宣布，1315 capital是一家总部位于费城、专注于医疗保健的成长型股权公司，将对其进行重大的成长资本投资。

The company was advised by Rob King and Crewe Capital, out of their New York office..

该公司由Rob King和Crewe Capital在其纽约办事处担任顾问。。

Continue Reading

继续阅读

Triple Ring stands side-by-side with innovators and entrepreneurs to solve hard problems, launch breakthrough products, and create new businesses. Working together with 1315 Capital, Triple Ring plans to accelerate its growth through both geographic expansion and extension of its R&D and product development services..

Triple Ring与创新者和企业家并肩而立，解决难题，推出突破性产品，创造新业务。Triple Ring计划与1315 Capital合作，通过地理扩张和研发及产品开发服务的扩展来加速增长。。

Silicon Valley MedTech and Life Sciences R&D Services business receives growth equity investment.

硅谷医疗技术和生命科学研发服务业务获得增长股权投资。

Post this

发布此

'Triple Ring Technologies has built a strong reputation in medical device and life sciences innovation, working with the world's top companies as well as with the brightest startups. The infusion of this growth capital will propel the company into a new phase of expansion, enabling us to capitalize on emerging opportunities and solidify our position as a market leader,' said Joseph Heanue, Chief Executive Officer of Triple Ring Technologies..

“三环科技在医疗器械和生命科学创新方面建立了良好的声誉，与世界顶级公司以及最聪明的初创公司合作。三环科技（Triple Ring Technologies）首席执行官约瑟夫·希努埃（JosephHealue）说，注入这些增长资本将推动公司进入新的扩张阶段，使我们能够利用新兴机遇，巩固我们的市场领导者地位。。

Michael Koby, Founding Partner of 1315 Capital, stated, 'We identified a significant opportunity to grow and scale a world-class services business that provides all necessary functions to develop and launch breakthrough healthcare products. We are thrilled to partner with Triple Ring to drive this vision.'      Craig Matturro, Principal at 1315 Capital, added, 'Triple Ring is the foundation of an engineering and outsourced R&D services platform around which we will  build an international leader in complex technology development for medical devices, life sciences, robotics, imaging, radiotherapy, and other technology-driven end markets.'       'We have worked with Triple Ring for over a decade and are pleased to have helped facilitate investment from 1315 Capital, which has provided the company the resources to be an industry standard.  As a later-stage growth investor, 1315's investment sends a strong signal regarding the potential for growth in the overall healthcare R&D and engineering services sector,' stated Rob King, Partner, at Crewe Capital.'Crewe and Rob's steady hand, thoughtful advice, and keen industry insight have added tremendous value to Triple Ring over the years as we have pursued our strategic objectives,' said Joseph Heanue.About Triple Ring TechnologiesTriple Ring Technologies, founded 2005, is a leader in the engineering services market.  The company is headquartered in Silicon Valley, with offices in Boston, Toronto, and Copenhagen.

1315 Capital的创始合伙人迈克尔·科比（MichaelKoby）表示，“我们发现了一个重要的机会，可以发展和扩大世界一流的服务业务，为开发和推出突破性的医疗保健产品提供所有必要的功能。我们很高兴能与Triple Ring合作来推动这一愿景。”1315 Capital负责人克雷格·马图罗（CraigMatturro）补充说，“三环是一个工程和外包研发服务平台的基础，我们将围绕这个平台，在医疗器械、生命科学、机器人、成像、放射治疗和其他技术驱动的终端市场的复杂技术开发方面建立一个国际领先者。”“我们与Triple Ring合作了十多年，很高兴能够帮助1315 Capital促进投资，这为该公司提供了成为行业标准的资源。克鲁资本（Crewe Capital）合伙人罗布·金（RobKing）表示，作为后期增长投资者，1315的投资发出了一个强烈的信号，表明整体医疗保健研发和工程服务行业的增长潜力约瑟夫·希奈（JosephHeanue）说，多年来，克鲁（Crewe）和罗布（Rob）坚定的双手、周到的建议以及敏锐的行业洞察力为Triple Ring带来了巨大的价值，因为我们一直在追求我们的战略目标。关于三环技术三环技术成立于2005年，是工程服务市场的领导者。该公司总部位于硅谷，在波士顿、多伦多和哥本哈根设有办事处。

They partner with clients in medical device and life sciences to create new technologies, launch innovative products, and start new ventures. Their capabilities span early R&D, product development, manufacturing, regulatory approval, market access, strategic partnership, and incubation. For more information, please visi.

他们与医疗器械和生命科学领域的客户合作，创造新技术，推出创新产品，并启动新企业。他们的能力涵盖早期研发、产品开发、制造、监管批准、市场准入、战略合作和孵化。有关更多信息，请访问。